Immuno-Oncology: Sneak Peek Of Preclinical Candidates Waiting In The Wings
Which immuno-oncology candidates are poised to begin their first-in-human clinical trials? How many sponsors already have partners or collaborators? What oncology indications have been proposed? And where will these trials take place? Citeline's Rachel L. Meighan-Mantha has the data.
Register for our free email digests: